- Report
- June 2025
- 186 Pages
Global
From €4003EUR$4,500USD£3,473GBP
- Report
- January 2025
- 182 Pages
Global
From €4003EUR$4,500USD£3,473GBP
- Report
- November 2025
- 197 Pages
Global
From €3504EUR$3,939USD£3,040GBP
- Report
- November 2025
- 195 Pages
Global
From €3504EUR$3,939USD£3,040GBP
- Report
- November 2025
- 194 Pages
Global
From €3504EUR$3,939USD£3,040GBP
- Report
- November 2025
- 182 Pages
Global
From €3504EUR$3,939USD£3,040GBP
- Report
- October 2025
- 192 Pages
Global
From €3504EUR$3,939USD£3,040GBP
- Report
- October 2025
- 180 Pages
Global
From €3504EUR$3,939USD£3,040GBP
- Report
- October 2025
- 196 Pages
Global
From €3504EUR$3,939USD£3,040GBP
- Report
- October 2025
- 184 Pages
Global
From €3504EUR$3,939USD£3,040GBP
- Report
- August 2025
- 199 Pages
Global
From €3504EUR$3,939USD£3,040GBP
- Report
- August 2025
- 199 Pages
Global
From €3504EUR$3,939USD£3,040GBP
- Report
- November 2025
- 180 Pages
Global
From €4003EUR$4,500USD£3,473GBP
- Report
- September 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- February 2025
- 200 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- April 2025
- 400 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- April 2025
- 250 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- April 2025
- 200 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- April 2025
- 200 Pages
Global
From €3994EUR$4,490USD£3,466GBP
- Report
- April 2025
- 200 Pages
Global
From €3994EUR$4,490USD£3,466GBP

The Cardiac Valve market is a segment of the Cardiovascular Devices industry, which includes a range of products used to diagnose and treat heart conditions. Cardiac valves are used to regulate the flow of blood through the heart, and can be either mechanical or biological. Mechanical valves are typically made of metal and are designed to last for many years, while biological valves are made of animal tissue and are designed to be replaced over time. Both types of valves are used to treat a variety of heart conditions, including aortic stenosis, mitral regurgitation, and tricuspid regurgitation.
The Cardiac Valve market is highly competitive, with a number of companies offering a range of products. Major players in the market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. Other companies in the market include CryoLife, Symetis, and Neovasc. Show Less Read more